Q2 2024 |
58 |
$1.23B |
+$398M |
-$311M |
+$87.1M |
ALBPRA, NEEPRS, APOPRA, JBBB, GFR
|
13F-HR |
8/14/2024, 02:01 PM |
Q1 2024 |
61 |
$1.15B |
+$603M |
-$540M |
+$62.5M |
ALBPRA, APOPRA, GFR, IHS, AXL
|
Restatement |
5/21/2024, 05:08 PM |
Q4 2023 |
49 |
$1B |
+$972M |
-$712M |
+$261M |
APOPRA, GFR, VTNR, FLR, IHS
|
13F-HR |
2/13/2024, 05:07 PM |
Q3 2023 |
112 |
$748M |
+$733M |
-$405M |
+$329M |
APOPRA, GFR, VCLT, VTNR, IHS
|
13F-HR |
11/14/2023, 11:31 AM |
Q2 2023 |
134 |
$428M |
+$140M |
-$184M |
-$44.2M |
VTNR, IHS, RIVN, SDRL, WOLF
|
13F-HR |
8/11/2023, 02:29 PM |
Q1 2023 |
162 |
$465M |
+$162M |
-$251M |
-$88.3M |
HYG, ABBV, VTNR, MANU, SDRL
|
13F-HR |
5/15/2023, 02:48 PM |
Q4 2022 |
274 |
$346M |
+$248M |
-$72.3M |
+$176M |
HYG, TIOA, VTNR, SDRL, TBSA
|
13F-HR |
2/13/2023, 10:14 AM |
Q3 2022 |
327 |
$167M |
+$72M |
-$6.95M |
+$65M |
LQD, TIOA, HYG, VTNR, TBSA
|
13F-HR |
11/14/2022, 10:26 AM |
Q2 2022 |
333 |
$101M |
+$26.1M |
-$10.6M |
+$15.5M |
TIOA, TBSA, TWTR, FICV, CSTAF
|
13F-HR |
8/15/2022, 01:13 PM |
Q1 2022 |
251 |
$90.9M |
$0 |
$0 |
|
TIOA, TBSA, ARTA, FICV, CSTAF
|
13F-HR |
5/13/2022, 04:45 PM |
Q4 2021 |
333 |
$188M |
$0 |
$0 |
|
TIOA, TBSA, ARTA, FICV, CSTAF
|
13F-HR |
2/11/2022, 03:02 PM |